The Investor
11 Mar 2026, 18:52
Abbott reported new research showing that cases of diabetic ketoacidosis (DKA) are increasing globally while ketone monitoring among people with diabetes remains inconsistent.
A long-term analysis of nearly 660,000 individuals in the United Kingdom found that DKA incidence more than tripled among people with Type 1 diabetes and increased sixfold among those with Type 2 diabetes, with many patients experiencing repeat episodes. Additional studies from France and the United States showed that many patients do not regularly test ketone levels despite awareness of the risks, and clinicians lack standardized guidance on ketone monitoring practices.
Abbott said the findings highlight the need for improved tools and clearer clinical guidance to detect rising ketones earlier and help prevent DKA, a potentially life-threatening complication of diabetes.
A long-term analysis of nearly 660,000 individuals in the United Kingdom found that DKA incidence more than tripled among people with Type 1 diabetes and increased sixfold among those with Type 2 diabetes, with many patients experiencing repeat episodes. Additional studies from France and the United States showed that many patients do not regularly test ketone levels despite awareness of the risks, and clinicians lack standardized guidance on ketone monitoring practices.
Abbott said the findings highlight the need for improved tools and clearer clinical guidance to detect rising ketones earlier and help prevent DKA, a potentially life-threatening complication of diabetes.
